Eaton Vance Management raised its position in Clorox Company (The) (NYSE:CLX) by 2.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 82,519 shares of the company’s stock after purchasing an additional 1,611 shares during the quarter. Eaton Vance Management owned about 0.06% of Clorox Company (The) worth $10,995,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nationwide Fund Advisors raised its stake in shares of Clorox Company (The) by 2.1% in the 1st quarter. Nationwide Fund Advisors now owns 36,264 shares of the company’s stock valued at $4,889,000 after acquiring an additional 751 shares during the period. Geneva Advisors LLC raised its stake in shares of Clorox Company (The) by 6.5% in the 1st quarter. Geneva Advisors LLC now owns 2,428 shares of the company’s stock valued at $327,000 after acquiring an additional 148 shares during the period. Great West Life Assurance Co. Can raised its stake in shares of Clorox Company (The) by 2.9% in the 1st quarter. Great West Life Assurance Co. Can now owns 270,950 shares of the company’s stock valued at $36,523,000 after acquiring an additional 7,626 shares during the period. Appleton Partners Inc. MA raised its stake in shares of Clorox Company (The) by 16.4% in the 1st quarter. Appleton Partners Inc. MA now owns 4,686 shares of the company’s stock valued at $632,000 after acquiring an additional 660 shares during the period. Finally, WASHINGTON TRUST Co raised its stake in shares of Clorox Company (The) by 558.0% in the 1st quarter. WASHINGTON TRUST Co now owns 11,963 shares of the company’s stock valued at $1,613,000 after acquiring an additional 10,145 shares during the period. Institutional investors own 71.28% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Holdings Boosted by Eaton Vance Management” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/13/clorox-company-the-clx-holdings-boosted-by-eaton-vance-management.html.

Shares of Clorox Company (NYSE CLX) opened at 135.57 on Wednesday. The stock has a market capitalization of $17.50 billion, a P/E ratio of 25.41 and a beta of 0.40. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The company’s 50-day moving average is $135.66 and its 200 day moving average is $135.26.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same quarter last year, the firm posted $1.30 earnings per share. Clorox Company (The)’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, equities analysts forecast that Clorox Company will post $5.66 EPS for the current fiscal year.

A number of equities research analysts have recently issued reports on the stock. BMO Capital Markets reissued an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday. Jefferies Group LLC reissued a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. Barclays PLC reissued an “equal weight” rating and issued a $136.00 price target (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. BidaskClub downgraded shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Finally, Zacks Investment Research raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research note on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $129.05.

In other news, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now owns 22,069 shares in the company, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. Insiders sold 21,242 shares of company stock worth $2,944,449 in the last 90 days. 0.74% of the stock is currently owned by insiders.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.